Mark Hronec

Mark Hronec is a Managing Partner at Scimitar. For more than 20 years he has helped over 80 companies, from eight-person biotechs to global pharma, build the organizations that get new medicines to patients faster, working across strategy, operations and quality. He shapes corporate and development strategy, builds the systems, processes and controls a company runs on, and puts in place quality foundations that stand up to FDA inspection. Whether a company is preparing its first filing or running a broad portfolio, he brings the operational maturity to move from first-in-human to approval quickly without cutting corners.